Parametric Portfolio Associates LLC Acquires 43,396 Shares of Becton Dickinson and Co (BDX)

Parametric Portfolio Associates LLC raised its holdings in Becton Dickinson and Co (NYSE:BDX) by 3.3% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,343,797 shares of the medical instruments supplier’s stock after purchasing an additional 43,396 shares during the quarter. Parametric Portfolio Associates LLC owned about 0.59% of Becton Dickinson and worth $263,317,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently modified their holdings of the company. Vanguard Group Inc. increased its stake in shares of Becton Dickinson and by 8.5% during the second quarter. Vanguard Group Inc. now owns 17,255,948 shares of the medical instruments supplier’s stock worth $3,366,809,000 after acquiring an additional 1,353,780 shares during the period. State Street Corp increased its stake in shares of Becton Dickinson and by 3.5% during the second quarter. State Street Corp now owns 10,270,221 shares of the medical instruments supplier’s stock worth $2,003,834,000 after acquiring an additional 342,873 shares during the period. Northern Trust Corp increased its stake in shares of Becton Dickinson and by 4.0% during the second quarter. Northern Trust Corp now owns 2,813,937 shares of the medical instruments supplier’s stock worth $549,028,000 after acquiring an additional 106,966 shares during the period. Fiera Capital Corp increased its stake in shares of Becton Dickinson and by 7.1% during the second quarter. Fiera Capital Corp now owns 2,782,146 shares of the medical instruments supplier’s stock worth $542,825,000 after acquiring an additional 183,372 shares during the period. Finally, Fundsmith LLP increased its stake in shares of Becton Dickinson and by 0.3% during the second quarter. Fundsmith LLP now owns 2,302,590 shares of the medical instruments supplier’s stock worth $449,258,000 after acquiring an additional 5,977 shares during the period. Institutional investors and hedge funds own 88.60% of the company’s stock.

A number of analysts recently commented on BDX shares. Royal Bank of Canada reissued a “hold” rating and set a $210.00 price objective on shares of Becton Dickinson and in a report on Wednesday, October 25th. Zacks Investment Research downgraded shares of Becton Dickinson and from a “hold” rating to a “sell” rating in a report on Monday, October 9th. Stifel Nicolaus reissued a “buy” rating and set a $245.00 price objective on shares of Becton Dickinson and in a report on Friday, November 3rd. Morgan Stanley boosted their price objective on shares of Becton Dickinson and from $205.00 to $245.00 and gave the stock an “equal weight” rating in a report on Friday, November 3rd. Finally, Wells Fargo & Company reissued a “positive” rating and set a $235.00 price objective (up previously from $225.00) on shares of Becton Dickinson and in a report on Tuesday, October 24th. They noted that the move was a valuation call. Four equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company. Becton Dickinson and has a consensus rating of “Buy” and an average price target of $218.36.

Shares of Becton Dickinson and Co (NYSE BDX) opened at $221.46 on Friday. Becton Dickinson and Co has a fifty-two week low of $161.50 and a fifty-two week high of $229.68. The stock has a market cap of $49,874.81, a PE ratio of 23.05, a price-to-earnings-growth ratio of 1.71 and a beta of 1.07. The company has a debt-to-equity ratio of 1.44, a current ratio of 5.58 and a quick ratio of 5.03.

Becton Dickinson and (NYSE:BDX) last announced its quarterly earnings results on Thursday, November 2nd. The medical instruments supplier reported $2.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.37 by $0.03. Becton Dickinson and had a net margin of 8.52% and a return on equity of 20.56%. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.14 billion. During the same quarter in the prior year, the firm earned $2.12 earnings per share. The company’s revenue for the quarter was down 2.0% compared to the same quarter last year. equities research analysts expect that Becton Dickinson and Co will post 10.63 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 29th. Shareholders of record on Friday, December 8th will be issued a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.35%. The ex-dividend date of this dividend is Thursday, December 7th. This is an increase from Becton Dickinson and’s previous quarterly dividend of $0.73. Becton Dickinson and’s dividend payout ratio is 64.52%.

TRADEMARK VIOLATION WARNING: “Parametric Portfolio Associates LLC Acquires 43,396 Shares of Becton Dickinson and Co (BDX)” was reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this report on another site, it was illegally copied and republished in violation of US and international copyright and trademark legislation. The correct version of this report can be viewed at https://www.com-unik.info/2017/12/16/parametric-portfolio-associates-llc-acquires-43396-shares-of-becton-dickinson-and-co-bdx.html.

Becton Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton Dickinson and Co (NYSE:BDX).

Institutional Ownership by Quarter for Becton Dickinson and (NYSE:BDX)

Receive News & Ratings for Becton Dickinson and Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit